ArticleBMC infectious diseases2016
Model estimates of the burden of outpatient visits attributable to influenza in the United States.
Article in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02019732 (Burden of Mild Outcomes Due to Influenza in the United States, July 2000 Through April 2009 and October 2010 to May 2011), which is not on this map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Burden of Mild Outcomes Due to Influenza in the United States, July 2000 Through April 2009 and October 2010 to May 2011
Who cites it
21 citing papers in PubMed, 31 citations in OpenAlex.
- Epidemiology and burden of influenza in healthy children aged 6 to 35 months: analysis of data from the placebo arm of a phase III efficacy trial.BMC infectious diseases · 2019Trial
- Article
- Acute Respiratory and Influenza Viruses Circulating in Kazakhstan During 2018-2024.Pathogens (Basel, Switzerland) · 2025Article
- Influenza A virus replicates productively in primary human kidney cells and induces factors and mechanisms related to regulated cell death and renal pathology observed in virus-infected patients.Frontiers in cellular and infection microbiology · 2024Article
- Disease burden and high-risk populations for complications in patients with acute respiratory infections: a scoping review.Frontiers in medicine · 2024Article
- Prediction of Influenza Complications: Development and Validation of a Machine Learning Prediction Model to Improve and Expand the Identification of Vaccine-Hesitant Patients at Risk of Severe Influenza Complications.Journal of clinical medicine · 2022Article
- A strategy to identify event specific hospitalizations in large health claims databases.BMC health services research · 2022Article
- Development of influenza-associated disease burden pyramid in Shanghai, China, 2010-2017: a Bayesian modelling study.BMJ open · 2021Article
- Reproductive sequelae of parental severe illness before the pandemic: implications for the COVID-19 pandemic.Fertility and sterility · 2020Article
- Variability in influenza vaccination opportunities and coverage among privately insured children.Vaccine · 2020Article
- Flucast: A Real-Time Tool to Predict Severity of an Influenza Season.JMIR public health and surveillance · 2019Article
- Influenza vaccination effectiveness for people aged under 65 years in Japan, 2013/2014 season: application of a doubly robust method to a large-scale, real-world dataset.BMC infectious diseases · 2019Article
- Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.Journal of virology · 2018Article
- Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018Article
- Preliminary results of official influenza and acute respiratory infection surveillance in two towns of Burkina Faso, 2013-2015.BMC infectious diseases · 2018Article
- Epidemiology and burden of influenza in the U.S. Department of Veterans Affairs.Influenza and other respiratory viruses · 2018Article
- Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010-2016.Influenza and other respiratory viruses · 2018Article
- Estimated incidence and number of outpatient visits for seasonal influenza in 2015-2016 in Beijing, China.Epidemiology and infection · 2017Article
- US healthcare costs attributable to type A and type B influenza.Human vaccines & immunotherapeutics · 2017Article
- A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.Human vaccines & immunotherapeutics · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough many studies have modelled the national burdens of hospitalizations and deaths due to influenza, few studies have considered the outpatient burden. To fill this gap for the United States (US), we applied traditional statistical modelling approaches to time series derived from large medical claims databases held in the private sector.
methodsWe accessed ICD-9-coded office visit data extracted from Truven Health Analytics' MarketScan Commercial database covering about one third of the US population <65 years during 2001-2009, and Medicare Supplemental data covering about one fifth of US seniors 65+ during 2006-2009. We extracted weekly time series of visits due to respiratory diagnoses, otitis media (OM), and urinary tract infections (UTI), a "negative control". We used multiple linear regression modelling to estimate age-specific influenza-related excess in office visits.
resultsIn the <65 year age group, in the 8 pre-pandemic seasons studied and for the broadest defined respiratory outcome, the model attributed an average of ~14.5 M (Standard deviation [SD] across seasons 3.9 million) office visits to influenza (rate of 5,581/100,000 population). Of these, ~80 % of visits occurred in the 5-17 and 18-49 age group. In school children aged 5-17 year olds and adult 18-64 year age groups the majority of visits were due to influenza B, while A/H3N2 explained most visits in children <5 year olds. The model further attributed ~2.2 M OM visits (SD across seasons 790,000) annually to influenza, of which 86 % of these occurred in children <18 years; this indicates that 6.4 % of all infants <2 years and 4.9 % of all toddlers aged 2-4 years in the US have an influenza-attributable outpatient visit with an OM diagnosis. In seniors 65 years and older, our model attributed ~0.7 M (SD across seasons 351,000) respiratory visits to influenza (rate of 1,887/100,000 population). The model identified no significant excess UTI (negative control) visits in most seasons.
conclusionsThis is to our knowledge a first study of the outpatient burden of influenza in the US in a large database. The model estimated that 10 % of all children <18 years and 4 % of the entire population <65 years seek outpatient care for respiratory illness attributable to influenza annually.
trial registrationClinicalTrial.gov, NCT02019732 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.